Skip to content
ppharmaranks
Menu

Delavirdine: uses, dosing, side effects & brands

Delavirdine is a medicine sold in the U.S. under one brand. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.

By the pharmaranks editorial teamReviewed against the FDA (openFDA label, NDC Directory & Enforcement) sourcesUpdated Jul 24, 2026How we research

Key facts

Available as
Tablet
Sold as
Rescriptor
Prescription?
Prescription only
Generic available?
Not in our catalog

Every delavirdine product we track (1)

Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.

Only one: Rescriptor.

Delavirdine and breastfeeding

From LactMed, the US National Library of Medicine’s Drugs and Lactation Database — quoted, not rewritten.

Delavirdine is no longer marketed in the United States. No published information is available on the use of delavirdine during breastfeeding. Delavirdine is not recommended during breastfeeding. Achieving and maintaining viral suppression with antiretroviral therapy decreases breastfeeding transmission risk to less than 1%, but not zero. Individuals with HIV who are on antiretroviral therapy with a sustained undetectable viral load and who choose to breastfeed should be supported in this decision. If a viral load is not suppressed, banked pasteurized donor milk or formula is recommended.

Full LactMed record for delavirdine: levels in milk, effects in breastfed infants, and the drugs it would consider instead

National Institute of Child Health and Human Development, record revised July 15, 2024. LactMed states its information is not a substitute for professional judgement.

What people report to the FDA about delavirdine

The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 92 reports naming delavirdine, and the FDA flagged 90% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:

  • lipodystrophy acquired67 reports
  • diplopia64 reports
  • eyelid ptosis64 reports
  • mitochondrial toxicity63 reports
  • progressive external ophthalmoplegia56 reports
  • ophthalmoplegia26 reports
  • extraocular muscle paresis15 reports
  • blood lactic acid increased12 reports

Read these as a signal, not a rate. A report does not mean delavirdine caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label section above.

Source: openFDA drug/event (FAERS), retrieved July 25, 2026.

Related calculators

Frequently asked questions

Can you take delavirdine with other medicines?

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run delavirdine against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

What forms does delavirdine come in?

Across the brands we track, delavirdine is currently marketed as tablet, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Is there a generic delavirdine?

We do not currently list a generic-labelled delavirdine product. That does not always mean none exists — it means none appears under a generic name in the FDA data we track. Ask your pharmacist.

Cite this page
APA
pharmaranks. (2026, July 24). Delavirdine: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/delavirdine
MLA
“Delavirdine: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/delavirdine.

We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.

Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.

Read the full FDA label for delavirdine on DailyMed (NIH) ↗.